HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bernward Passlick Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sienel, W. Articles by Passlick, B. Search for Related Content PubMed PubMed Citation Articles by Sienel, W. Articles by Passlick, B. Related Collections Lung - basic science Lung - cancer

Eur J Cardiothorac Surg 2003;23:451-456
© 2003 Elsevier Science NL

Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance

^a Department of Surgery, Chirurgische Klinik und Poliklinik – Innenstadt, University of Munich, 80336 Munich, Germany
^b Department of Thoracic Surgery, Asklepios Fachkliniken München-Gauting, Robert-Koch-Allee 2, D-82131 Gauting, Germany
^c Institute for Tumor Biology, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany

Received 27 September 2002; received in revised form 18 December 2002; accepted 20 December 2002.

^* Corresponding author. Tel.: 89-85791-7333; fax: 89-85791-7335
e-mail: passlick{at}lrz.uni-muenchen.de

Objectives: This prospective study was performed to examine whether tumour cells are detectable in the tumour draining vein of patients with non-small cell lung cancer. Furthermore, the impact of these cells on the clinical course was analysed. Patients and Methods: Sixty-two consecutive patients with completely resected primary non-small cell lung cancer (pT1-4 pN0-2 M0) were admitted to the study. Pulmonary venous blood was drawn at the time of surgery for primary non-small cell lung cancer. The tumour draining vein was punctured subsequent to thoracotomy prior to manipulation of the tumour. The blood samples were examined for occult tumour cells by immunocytochemical staining of cytospins using the pancytokeratin antibody A45-B/B3 (murine immunoglobulin G1; Micromet, Munich, Germany). Results: Disseminated cancer cells in pulmonary venous blood were observed in 11 of 62 patients (18%) and did not correlate with standard clinico-pathological parameters. In patients without involvement of mediastinal lymph nodes (pN0–pN1), detection of occult tumour cells was an independent prognostic parameter for unfavourable outcome: log rank analysis showed a significant association of occult tumour cells in pulmonary venous blood with shortened cancer-related survival (P=0.019) and multivariate regression analysis demonstrated an independently significant (P=0.004) prognostic impact. Conclusion: The present study shows that disseminated cancer cells in the pulmonary venous blood are detectable in about 20% of the patients with operable non-small cell lung cancer and that they are associated with a poor clinical outcome. Therefore, the detection of such cells might be useful for the identification of patients who benefit from adjuvant therapy. Furthermore, in order to avoid an additional systemic spread of tumour cells intraoperatively, the pulmonary veins should be ligated first during lung cancer surgery.

Key Words: Pulmonary vein • Circulating cells • Non-small cell lung cancer • Survival rate • Survival analysis • Neoplasm staging

This article has been cited by other articles:

				L. M. Backhus, E. Sievers, G. Y. Lin, R. Castanos, R. D. Bart, V. A. Starnes, and R. M. Bremner Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 297 - 303. [Abstract] [Full Text] [PDF]